Evidence map›Paper›PMID 33195319›Full record

ReviewFrontiers in medicine2020

Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid).

Bahaa Abu-Raya, Giovanni Battista Migliori, Miguel O'Ryan, Kathryn Edwards, Antoni Torres, Jan-Willem Alffenaar, Anne-Grete Märtson, Rosella Centis, Lia D'Ambrosio, Katie Flanagan and 20 more

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Apocalyptic COVID-19 mortality and BMI: a J-shape relationship?Acta bio-medica : Atenei Parmensis · 2022
    Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2022
    Article
  13. Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Bahaa Abu-RayaDepartment of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Giovanni Battista MiglioriIstituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy.
Miguel O'RyanFaculty of Medicine, Institute of Biomedical Sciences and Institute of Immunology and Immunotherapy, University of Chile, Santiago, Chile.
Kathryn EdwardsVanderbilt University Medical Center, Nashville, TN, United States.
Antoni TorresRespiratory and Intensive Care Unit, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Jan-Willem AlffenaarFaculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia.
Anne-Grete MärtsonDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Rosella CentisIstituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy.
Lia D'AmbrosioPublic Health Consulting Group, Lugano, Switzerland.
Katie FlanaganUniversity of Tasmania, Monash University, RMIT University, Hobart, Australia.
Ivan HungQueen Mary Hospital, Hong Kong, China.
Fulvio LauretaniGeriatric Clinic Unit, Department of Medicine and Surgery, University-Hospital of Parma, University of Parma, Parma, Italy.
Chi Chi LeungHong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong, China.
Elke LeuridanFaculty of Medicine and Health Sciences, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
Kirsten MaertensFaculty of Medicine and Health Sciences, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
Marcello Giuseppe MaggioGeriatric Clinic Unit, Department of Medicine and Surgery, University-Hospital of Parma, University of Parma, Parma, Italy.
Simon NadelSt. Mary's Hospital, London, United Kingdom.
Niel HensData Science Institute, Hasselt University, Hasselt, Belgium.
Hubert NiestersUniversitair Medisch Centrum Groningen, Groningen, Netherlands.
Albert OsterhausUniversity of Veterinary Medicine, Hanover, Germany.
Emanuele PontaliDepartment of Infectious Diseases, Galliera Hospital, Genoa, Italy.
Nicola PrincipiUniversità degli Studi di Milano, Milan, Italy.
Denise Rossato SilvaUniversidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
Saad OmerDepartment of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, United States.
Antonio SpanevelloIstituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy.
Nicola SverzellatiRadiology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Tina TanFeinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Evanston, IL, United States.
Juan Pablo Torres-TorretiDepartment of Pediatrics and Pediatric Surgery, Faculty of Medicine, Dr. Luis Calvo Mackenna Hospital, University of Chile, Santiago, Chile.
Dina ViscaIstituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy.
Susanna EspositoPediatric Clinic, Department of Medicine and Surgery, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.

Indexed as

coronavirusCOVID-19infection controlintensive care managementphysical distancingpreventionSARS-CoV-2workplace safety

Identifiers

PMID33195319
PMCPMC7662576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.